CLOV vs FUBO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

CLOV

48.9
AI Score
VS
FUBO Wins

FUBO

52.7
AI Score

Investment Advisor Scores

CLOV

49score
Recommendation
HOLD

FUBO

53score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLOV FUBO Winner
Revenue 749.19M 3.12B FUBO
Net Income 27.33M -8.08M CLOV
Net Margin 3.6% -0.3% CLOV
Operating Income 27.33M -29.42M CLOV
ROE 8.1% -1.0% CLOV
ROA 3.9% -0.2% CLOV
Total Assets 697.73M 3.98B FUBO
Current Ratio 1.33 0.99 CLOV
Free Cash Flow 107.04M -412.98M CLOV

Relative Price Performance (Last 90 Days)

CLOV 1M: -22.6% · 3M: +51.6% FUBO 1M: -12.2% · 3M: -28.2%

Current Technical Phase

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.3 · Price: $4.17

FUBO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $8.85

Fundamentals Snapshot

Metric CLOV FUBO
Market Cap
Forward P/E 41.7 18.8
Trailing P/E 2.3
Revenue (TTM)
Revenue Growth 0.6% 0.4%
Gross Margin 0.2% 0.0%
Operating Margin 0.0% 0.0%
EPS -0.12 3.73
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, FUBO is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.